Novel T cell receptor therapy shows early anti-tumor activity
byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A
Updated on: January 15,2024
20

Novel T cell receptor therapy shows early anti-tumor activity
byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A
Updated on:January 15,2024
20
